Reynolds CP, Seeger RC, Vo DD, Ugelstad D, and Wells J : Model system for removing neuroblastoma cells from bone marrow using monoclonal antibodies and magnetic immunobeads. Cancer Research 46:5882-5886, 1986.

Seeger RC, Reynolds CP : Treatment of high risk solid tumors of childhood with intensive therapy and autologous bone marrow transplantation. Pediatric Clinics of North America 38:393-424, 1991.

Devasthall SD, Gordeuk VR, Brittenham GM, Bravo JR, Hughes MA, Keating LJ. Bioavailability of carbonyl iron: a randomized, double-bind study. Eur J Haematol 1991: 46: 272-278.

Tang Y and Reynolds CP : In Preparation.

Matthay KK, Seeger, Reynolds CP, Stram D, O'Leary M, Harris RE, Selch M, Atkinson J, Haase GM, Ramsay NK : Allogeneic vs. autologous purged bone marrow transplantation for neuroblastoma: A report from the Childrens Cancer Group. J Clinical Oncology 12:2382-2389, 1994.

Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, Swift P, Shamada H, Black CG, Brodeur GM, Gerbing R, Reynolds CP : Treatment of high risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. New Eng J Med 341:1165-1173, 1999.

Moss TJ, Reynolds CP, Sather H, Romansky S, and Seeger RC : Immunocytology improves detection of marrow metastases and provides prognostic information for patients with neuroblastoma. New England J Medicine 324:219-226, 1991.

Seeger RC, Reynolds CP,Gallego R, Stram DO, Gerbing RB, Matthay KK : Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: A Children's Cancer Group Study. J Clinical Oncology, 18:4067-4076, 2000.

Sutherland DR, Anderson L, Keeney M, Nayar R, Chin Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother 1996; 5:213-226.